Circ_0020123 Increases ZFX Expression to Facilitate Non-Small Cell Lung Cancer Progression by Sponging miR-142-3p

References

• Mao Y, Yang D, He J, Krasna MJ. Epidemiology of lung cancer. Surg Oncol Clin N Am. 2016;25(3):439–445. doi:10.1016/j.soc.2016.02.00127261907
   PubMed Web of Science ®Google Scholar
• Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473. doi:10.1016/j.mcna.2018.12.00630955514
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.01331378236
   PubMed Web of Science ®Google Scholar
• Rusch VW. Stage III non-small cell lung cancer. Semin Respir Crit Care Med. 2016;37(5):727–735. doi:10.1055/s-0036-159211227732994
   PubMed Web of Science ®Google Scholar
• Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27(148):167–170.31095926
   PubMed Web of Science ®Google Scholar
• Nagano T, Tachihara M, Nishimura Y. Molecular mechanisms and targeted therapies including immunotherapy for non-small cell lung cancer. Curr Cancer Drug Targets. 2019;19(8):595–630.30526458
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-731395983
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ. Circular RNA – New member of noncoding RNA with novel functions. Exp Biol Med. 2017;242(11):1136–1141. doi:10.1177/1535370217708978
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319–336. doi:10.1016/j.trecan.2020.01.01232209446
   PubMed Web of Science ®Google Scholar
• Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127. doi:10.1016/j.gde.2017.11.00729245064
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267–274. doi:10.1016/j.ebiom.2018.07.03630078734
   PubMed Web of Science ®Google Scholar
• Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220. doi:10.1186/s12967-018-1593-530092792
   PubMed Web of Science ®Google Scholar
• Dori M, Bicciato S. Integration of bioinformatic predictions and experimental data to identify circRNA-miRNA associations. Genes. 2019;10(9):642. doi:10.3390/genes10090642
   PubMed Web of Science ®Google Scholar
• Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 2017;403:305–317. doi:10.1016/j.canlet.2017.06.02728687357
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Z, Zhang M, et al. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2019;38(1):466. doi:10.1186/s13046-019-1436-031718694
   PubMed Web of Science ®Google Scholar
• Cao X, Li F, Shao J, et al. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4. J Biochem. 2020.
   Google Scholar
• Lu J, Zhu Y, Qin Y, Chen Y. CircNFIX acts as a miR-212-3p sponge to enhance the malignant progression of non-small cell lung cancer by up-regulating ADAM10. Cancer Manag Res. 2020;12:9577–9587. doi:10.2147/CMAR.S27230933061643
   PubMed Web of Science ®Google Scholar
• Bi R, Wei W, Lu Y, et al. High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis. Aging. 2020;12(17):17343–17352. doi:10.18632/aging.10372232927434
   PubMedGoogle Scholar
• Wang L, Zhao L, Wang Y. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by sponging miR-590-5p to regulate THBS2. Cancer Cell Int. 2020;20:387. doi:10.1186/s12935-020-01444-z32831647
   PubMed Web of Science ®Google Scholar
• Wan J, Hao L, Zheng X, Li Z. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression. Biochem Biophys Res Commun. 2019;515(2):303–309. doi:10.1016/j.bbrc.2019.05.15831153639
   PubMed Web of Science ®Google Scholar
• Qu D, Yan B, Xin R, Ma T. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 2018;8(8):1387–1402.30210911
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang X, Wang S, Lin X, Xu L. Circ_0084927 facilitates cervical cancer development via sponging miR-142-3p and upregulating ARL2. Cancer Manag Res. 2020;12:9271–9283. doi:10.2147/CMAR.S26359633061617
   PubMed Web of Science ®Google Scholar
• Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-beta1 axis. Mol Cancer. 2020;19(1):117. doi:10.1186/s12943-020-01235-032713345
   PubMed Web of Science ®Google Scholar
• Liang L, Fu J, Wang S, et al. MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1. Acta Pharm Sin B. 2020;10(6):1036–1046. doi:10.1016/j.apsb.2019.11.00932642410
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou X, Qiao J, Bao A. MiR-142-3p overexpression increases chemo-sensitivity of NSCLC by inhibiting HMGB1-mediated autophagy. Cell Physiol Biochem. 2017;41(4):1370–1382. doi:10.1159/00046789628427045
   PubMedGoogle Scholar
• Xiao P, Liu WL. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Int J Clin Exp Pathol. 2015;8(9):10800–10807.26617792
   PubMed Web of Science ®Google Scholar
• Liu J, Tian W, Zhang W, et al. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing beta-catenin expression. Biomed Pharmacother. 2019;114:108847. doi:10.1016/j.biopha.2019.10884730970294
   PubMed Web of Science ®Google Scholar
• Smith-Raska MR, Arenzana TL, D’Cruz LM, et al. The transcription factor Zfx regulates peripheral T cell self-renewal and proliferation. Front Immunol. 2018;9:1482. doi:10.3389/fimmu.2018.0148230022979
   PubMed Web of Science ®Google Scholar
• Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007;129(2):345–357. doi:10.1016/j.cell.2007.03.01417448993
   PubMed Web of Science ®Google Scholar
• Zhou Y, Su Z, Huang Y, et al. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res. 2011;30:114. doi:10.1186/1756-9966-30-11422185393
   PubMed Web of Science ®Google Scholar
• Weisberg SP, Smith-Raska MR, Esquilin JM, et al. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. Cell Rep. 2014;6(3):528–540. doi:10.1016/j.celrep.2014.01.00724485662
   PubMed Web of Science ®Google Scholar
• Yan X, Shan Z, Yan L, et al. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients. Oncotarget. 2016;7(15):19680–19692. doi:10.18632/oncotarget.754726967242
   PubMedGoogle Scholar
• Li K, Zhu ZC, Liu YJ, et al. ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299. Int J Clin Exp Pathol. 2013;6(11):2460–2467.24228108
   PubMed Web of Science ®Google Scholar
• Zha W, Cao L, Shen Y, Huang M. Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS One. 2013;8(9):e74175. doi:10.1371/journal.pone.007417524066116
   PubMed Web of Science ®Google Scholar
• Jiang M, Xu S, Yue W, et al. The role of ZFX in non-small cell lung cancer development. Oncol Res. 2012;20(4):171–178. doi:10.3727/096504012X1354816598749323461064
   PubMed Web of Science ®Google Scholar